• Policy
• President Visited KDCA to Strengthen Bio-Health Investment
• by Lee, Hye-Kyung May 31, 2022 06:05am

• Company
• Obesity treatment market expands 66% in 4 yrs
• by Chon, Seung-Hyun May 30, 2022 05:42am

• Policy
• Will Dukarb Plus next month rise as Boryung’s savior?
• by Lee, Tak-Sun May 30, 2022 05:42am

• Company
• Interleukin inhibitor market doubles in 2 years
• by May 30, 2022 05:41am

• Company
• Samjin recently filed a request against Janssen Korea
• by Kim, Jin-Gu May 30, 2022 05:41am

• Company
• The release of Singrix for NIP is expected
• by Moon, sung-ho May 30, 2022 05:41am

• Company
• Expanded indication for Jardiance
• by jung, sae-im May 29, 2022 05:15pm

• Company
• Lorviqua, which is about to be reimbursed, has settled
• by Eo, Yun-Ho May 29, 2022 05:15pm

• Policy
• Chong Kun Dang faces Hanmi due to Rivaroxaban 2.5mg
• by Lee, Tak-Sun May 29, 2022 05:14pm

• Company
• Janssen takes sole lead in the ₩50 billion PAH market
• by Kim, Jin-Gu May 27, 2022 05:56am